Overview

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Status:
Completed

Trial end date:
2016-08-11

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the potential of DFD06 cream to suppress the HPA (hypothalamic-pituitary-adrenal) axis as compared to clobetasol propionate cream, 0.05% cream when applied twice daily for 15 days.

Phase:

Phase 2

Details

Lead Sponsor:

Promius Pharma, LLC

Treatments:

Clobetasol